Stimulating Respiration Function Patents (Class 607/42)
-
Patent number: 11806526Abstract: A device for treating sleep disordered breathing includes a stimulation element to stimulate an airway-patency-related nerve.Type: GrantFiled: September 4, 2020Date of Patent: November 7, 2023Assignee: INSPIRE MEDICAL SYSTEMS, INC.Inventors: Darrell Wagner, Quan Ni, John Rondoni, Dave Dieken
-
Patent number: 11806537Abstract: A system and method for treating sleep apnea includes inserting an implantable pulse generator subcutaneously within a body of a patient and connecting a lead to the pulse generator. The lead is inserted within the vasculature and advanced transvenously through the vasculature until a stimulation portion of the lead becomes positioned in close proximity to the hypoglossal nerve. A nerve-stimulation signal is applied to the hypoglossal nerve via the stimulation portion of the lead.Type: GrantFiled: August 6, 2021Date of Patent: November 7, 2023Assignee: INSPIRE MEDICAL SYSTEMS, INC.Inventors: Quan Ni, Mark A. Christopherson, Timothy P. Herbert, John Rondoni
-
Patent number: 11786177Abstract: An oral appliance for treating sleep apnea in a user includes a mouthpiece configured for being positioned in an oral cavity of the user, and at least one pulse oximeter attached to the mouthpiece. According to an aspect, the pulse oximeter is configured to monitor actual oxygen saturation levels of hemoglobin of the user when the oral appliance is positioned in the oral cavity of the user. The oral appliance may include an additional sensor attached to the mouthpiece that includes at least one of an airflow sensor, a pressure sensor, a noise detector, and an actigraphy sensor.Type: GrantFiled: June 30, 2022Date of Patent: October 17, 2023Assignee: Achaemenid, LLCInventor: Reza Radmand
-
Patent number: 11779217Abstract: A method comprises establishing communication between a therapy device implantable in a patient and a consumer electronic device operable by the patient. The method comprises controlling, by the consumer electronic device, a predetermined set of therapy device functions in response to patient inputs to the consumer electronic device. The method also comprises transmitting therapy data from the therapy device to the consumer electronic device. The method further comprises presenting therapy data on a display of the consumer electronic device.Type: GrantFiled: May 29, 2019Date of Patent: October 10, 2023Assignee: Inspire Medical Systems, Inc.Inventors: John Rondoni, David Todd Dieken
-
Patent number: 11776146Abstract: The present technology relates to the field of medical monitoring, and, in particular, to non-contact detecting and monitoring of patient breathing. Systems, methods, and computer readable media are described for calculating a change in depth of a region of interest (ROI) on a patient. In some embodiments, the systems, methods, and/or computer readable media can identify steep changes in depths. For example, the systems, methods, and/or computer readable media can identify large, inaccurate changes in depths that can occur at edge regions of a patient. In these and other embodiments, the systems, methods, and/or computer readable media can adjust the identified steep changes in depth before determining one or more patient respiratory parameters.Type: GrantFiled: March 18, 2022Date of Patent: October 3, 2023Assignee: Covidien LPInventors: Paul S. Addison, Dominique Jacquel, Philip Smit
-
Patent number: 11771901Abstract: An apparatus includes an implantable stimulator to treat sleep disordered breathing (SDB) and at least one electrode associated with the stimulator. The apparatus includes a therapy device arranged to be implanted within a head/neck region of a patient. The therapy device includes a microstimulator including a housing to encapsulate at least stimulation circuitry, a rechargeable power element, and a control portion including a therapy manager to control the stimulation circuitry.Type: GrantFiled: November 12, 2021Date of Patent: October 3, 2023Assignee: INSPIRE MEDICAL SYSTEMS, INC.Inventors: John Rondoni, David Dieken, Kevin Verzal
-
Patent number: 11759636Abstract: An apparatus and method for treating obstructive sleep apnea includes a pulse oximeter, a source of transcutaneous electrical stimulation having a pair of electrodes for delivering TES to a person, and a controller. The electrodes are adapted to be applied to the person's skin adjacent the person's upper airway to stimulate one or more nerves or muscles in the upper airway when TES is applied to the electrodes. The controller is adapted to receive blood oxygen data from the pulse oximeter and is programmed to apply TES when the blood oxygen indicates that the person's blood oxygen is below a predetermined threshold, so as to increase a resting tone of the person's tongue.Type: GrantFiled: August 5, 2020Date of Patent: September 19, 2023Inventor: David Goldfarb
-
Patent number: 11752342Abstract: Systems and methods for a neuromodulation system are provided. In one example, the neuromodulation system includes a stimulation element, a stimulation controller, and a stimulation feedback acquisition system that includes a reference trigger input module configured such that the temporal relationship between a provided stimulation via the stimulation element and the stimulation controller, and a stimulation response received by the stimulation feedback acquisition system can be characterized.Type: GrantFiled: February 11, 2020Date of Patent: September 12, 2023Assignee: Onward Medical N.V.Inventors: Jurriaan Bakker, Hans Pflug, Robin Brouns, Vincent Delattre
-
Patent number: 11752327Abstract: The present disclosure is in the field of sleep and respiratory care. In particular, the present disclosure provides means and methods for decreasing the respiratory effort of a sleeping subject. The present disclosure also provides means and methods for treating the snoring of a sleeping subject.Type: GrantFiled: August 22, 2022Date of Patent: September 12, 2023Assignee: Sunrise SAInventor: Pierre Martinot
-
Patent number: 11744968Abstract: A positive airway pressure apparatus is automatically adjusting. Pressure increases in response to apnea events when the apparatus is in one or more responsive states. Pressure does not increase in response to apnea events when the apparatus is in a non-responsive state. The apparatus switches between responsive and nonresponsive states depending upon any of a number of different criteria that help differentiate between open airway apnea events and closed airway apnea events.Type: GrantFiled: July 1, 2021Date of Patent: September 5, 2023Assignee: Fisher & Paykel Healthcare LimitedInventors: David Robin Whiting, Andrew Gordon Gerred, Fiona Elizabeth Cresswell
-
Patent number: 11707618Abstract: A trans mucosal neuromuscular electrical stimulation device including a mouthpiece, electrodes associated with the mouthpiece. The device and/or mouthpiece incorporates electrical circuitry operatively connecting to the electrodes to a power source and is configured to provide, in use, electrical stimulation to one or more palate and/or tongue muscles via the electrodes through the oral mucosa. The treatment regime, including the location of stimulation and the parameters used, is designed to increase resting muscle tone and/or muscle tone during sleep.Type: GrantFiled: January 30, 2020Date of Patent: July 25, 2023Assignee: Signifier Medical Technologies LimitedInventor: Anshul Sama
-
Patent number: 11684271Abstract: A wearable device for sensing vital signs includes a housing defining an interior cavity. An optical unit is positioned inside the interior cavity. The optical unit includes one or more light emitters that emit optical signals, at least one polarizer orientated to block optical signals having a predetermined polarity direction, and one or more light sensors that receive optical signals that pass through the at least one polarizer. An acoustic unit is positioned inside the interior cavity, and has a microphone to receive acoustic signals that enter into the interior cavity. The acoustic signals are used to non-invasively estimate blood pressure.Type: GrantFiled: February 23, 2021Date of Patent: June 27, 2023Assignee: Welch Allyn, Inc.Inventors: Lei Guo, Thaddeus J. Wawro
-
Patent number: 11678838Abstract: Approaches to determining a sleep fitness score for a user are provided, such as may be based upon monitored breathing disturbances of a user. The system receives user state data generated over a time period by a combination of sensors provided via a wearable tracker associated with the user. A system can use this information to calculate a sleep fitness score, breathing disturbance score, or other such value. The system can classify every minute within the time period as either normal or atypical, for example, and may provide such information for presentation to the user.Type: GrantFiled: December 29, 2020Date of Patent: June 20, 2023Assignee: FITBIT, INC.Inventors: Suraj Gowda, Conor Joseph Heneghan, Shelten Gee Jao Yuen, Anjian Wu, Daniel Joel Freschl, Peter W. Richards, Chris H. Sarantos, Jonathan Wonwook Kim
-
Patent number: 11666270Abstract: A sleep apnea and obesity comorbidity treatment system includes a transceiver and a control module. The control module is configured to: receive sensor data, where the sensor data is indicative of a glucose level of a patient and a ketones level of the patient, transmit the sensor data to a remote feedback device, receive feedback information from the remote feedback device based on the sensor data, and where the feedback information provides indications to the patient to maintain or alter a behavior of the patient based on the glucose level and the ketones level, and based on the feedback information, performing an operation to maintain or alter at least one of a diet or physical activity of the patient.Type: GrantFiled: April 30, 2020Date of Patent: June 6, 2023Assignee: Medtronic Xomed, Inc.Inventors: Osvaldo Andres Barrera, Avram Scheiner, Randal C. Schulhauser, Joe Sartor, Patrick W. Kinzie, Jason C. Lee
-
Patent number: 11666478Abstract: Maxillary devices and Mandibular devices each have a first housing connectable to a tooth of a user or connectable or integral with a teeth covering, wherein the housing encloses an on-board circuit board and a power source. The first housing of the maxillary devices has a tooth connecting portion, a palate housing portion and/or a buccal housing portion. The first housing of the mandibular devices has a tooth connecting portion and a sublingual portion. Each of the palate housing portion and the buccal housing portion enclose a stimulator having an electrode electrically connected to the on-board circuit board and the power source, and can enclose a sensor and/or a medicament dispenser. The sublingual portion encloses a sensor and a medicament dispenser each of which are in electrical communication with the microprocessor of the on-board circuit board.Type: GrantFiled: March 18, 2020Date of Patent: June 6, 2023Assignee: SLEEP SOLUTIONS OF TEXAS, LLCInventor: Raghavendra Vitthalrao Ghuge
-
Patent number: 11666477Abstract: Lingual repositioning devices have a mandibular piece having a teeth covering and a first housing proximate either a left molar portion or a right molar portion of the teeth covering. The first housing includes a stimulator protrusion extending therefrom at a position to extend toward a tongue of a user and to contact a lingual muscle of the tongue or includes a sensor portion extending therefrom at a position to extend toward a tongue of a user and to be positioned under the tongue. The stimulator protrusion encloses a stimulator and the first housing encloses a power source electrically connected to a circuit board and electrically connected to an electrode of a stimulator. A second housing at the other of the left or right molar portions has a stimulator protrusion or a sensor portion. The first and second housings may be removably attachable to the teeth covering.Type: GrantFiled: February 7, 2020Date of Patent: June 6, 2023Assignee: SLEEP SOLUTIONS OF TEXAS, LLCInventor: Raghavendra Vitthalrao Ghuge
-
Patent number: 11666757Abstract: Hemodynamic performance of a heart may be improved by determining, from a location associated with a diaphragm, an occurrence of a valid cardiac event; and then delivering asymptomatic electrical stimulation therapy directly to the diaphragm at termination of a diaphragmatic stimulation delay period that is timed relative to the occurrence of the valid cardiac event. The diaphragmatic stimulation delay period may be automatically established by sensing a plurality of cardiac events directly from a diaphragm; and for each of the sensed cardia events, determining whether the sensed cardiac event represents a valid cardiac event or a non-valid cardiac event. The diaphragmatic stimulation delay period is then calculated based on a plurality of sensed cardia events that are determined to be valid.Type: GrantFiled: September 16, 2021Date of Patent: June 6, 2023Assignee: VisCardia, Inc.Inventors: Peter T. Bauer, Edward Chinchoy, Jay Snell
-
Patent number: 11666271Abstract: A method of detecting sleep apnea includes generating a cardiac signal indicating activity of a heart of a patient. The method further includes determining a short-term average heart rate and a long-term average heart rate. The method further includes determining a start and end of a heart rate cycle based on the short-term average heart rate and the long-term average heart rate. The method further includes determining physiological parameter values occurring during the heart rate cycle. The method further includes determining whether patient has or has not experienced a sleep apnea event based on whether one or more conditions are satisfied by one or more parameter values for one or more heart rate cycles and responsively generating an indication that patient has or has not experienced a sleep apnea event.Type: GrantFiled: December 9, 2020Date of Patent: June 6, 2023Assignee: Medtronic, Inc.Inventors: Yong K. Cho, Eduardo N. Warman, Gautham Rajagopal
-
Patent number: 11654283Abstract: An implantable neurostimulator system including an electrical lead having formed thereon a pair of bipolar electrodes, the electrical lead is configured for placement of the pair of bipolar electrodes proximate protrusor muscles of a patient. The system also includes a pulse generator electrically connected to the electrical lead and configured to deliver electrical energy to the pair of bipolar electrodes, the pulse generator having mounted therein a sensor configured to detect one or more physiological parameters, a memory, a control circuit, and a telemetry circuit.Type: GrantFiled: January 24, 2020Date of Patent: May 23, 2023Assignee: MEDTRONIC XOMED, INC.Inventors: Wondimeneh Tesfayesus, Randal Schulhauser, Avram Scheiner
-
Patent number: 11642175Abstract: In an example, a system is disclosed for registering an anatomical model to an anatomical structure of a patient. The system includes an anatomical measurement wire (“AMW”) configured to be navigated within the anatomical structure, the AMW comprising at least one sensor. A tracking system is configured to provide tracking data representing multiple positions of the sensor in a spatial coordinate system. A computing device is configured to generate a tracking point cloud based on the tracking data. The computing device is configured to register the predetermined anatomical model with the anatomical structure of the patient by matching the tracking point cloud with the model point cloud with respect to the predetermined anatomical model based on a quality metric.Type: GrantFiled: November 14, 2019Date of Patent: May 9, 2023Assignee: CENTERLINE BIOMEDICAL, INC.Inventors: Karl J. West, Vikash R. Goel
-
Patent number: 11633599Abstract: A system for electrical ventilation stimulation of a patient including an implantable nerve stimulator including a stimulation circuit and a pulse generator that produces biphasic charge-balanced pulses to stimulate a phrenic nerve, an external digital programming device having near field communication transmission and a digital interface, and wherein the external digital programming device is used to control settings of the implantable nerve stimulator.Type: GrantFiled: October 10, 2018Date of Patent: April 25, 2023Assignees: NORTHWESTERN UNIVERSITY, ANN AND ROBERT H. LURIE CHILDREN'S HOSPITAL OF CHICAGOInventors: Alexey Revinski, Kirby D. Gong, Emma S. Cripe, Michelle Wang, Matthew R. Glucksberg, Debra E. Weese-Mayer, Anthony Chin
-
Patent number: 11623086Abstract: Disclosed is a system for stimulation of a subject. The stimulation may be to provide therapy to treat the subject. Stimulation may be of selected muscle groups and/or portions.Type: GrantFiled: January 24, 2020Date of Patent: April 11, 2023Assignee: MEDTRONIC XOMED, INC.Inventors: Avram Scheiner, James Britton Hissong, Rebecca J. Haag, Randal C. Schulhauser
-
Patent number: 11612708Abstract: Devices, systems and methods are provided for controlling the operation of a breathing assistance device for a user. The controller may include an input for receiving sensor data to measure at least one airflow parameter of the user's airflow; a memory unit that stores at least one machine learning model and at least one classifier or predictor; and a processor that is configured to perform measurements and to generate a control signal for adjusting the operation of the breathing assistance device for a current monitoring time period by: obtaining measured air pressure and/or airflow data and measured FOT data during a current monitoring time period; performing feature extraction on the measured data to obtain feature values that are used by the machine learning model employed by the at least one classifier or predictor to determine a property of the user; and adjusting the control signal based on the determined property.Type: GrantFiled: April 22, 2022Date of Patent: March 28, 2023Assignee: NovaResp Technologies Inc.Inventors: Hamed Hanafialamdari, Scott Lowe, Stephen Driscoll, Luke Hacquebard, David Cecil Roach, Klaus Michael Schmidt
-
Patent number: 11607548Abstract: An apparatus, system and technique selectively eliminates the noxious signal components in a neuronal signal by creating an interfering electrical signal that is tuned to a given frequency corresponding to the oscillatory pattern of the noxious signal, resulting in a modified neuronal signal that substantially reproduces a normal, no-pain neuronal signal. The disclosed system and technique of pain relief is based on the hypothesis that the temporal profile of pain signals encodes particular components that oscillate at unique and quantifiable frequencies, which are responsible for pain processing in the brain.Type: GrantFiled: August 8, 2018Date of Patent: March 21, 2023Assignee: Lumbrera LLCInventors: Ricardo Vallejo, David Leonardo Cedeno, William J. Smith
-
Patent number: 11565112Abstract: The present disclose generally relates to systems and methods for active titration of one or more cranial or peripheral nerve stimulators to treat obstructive sleep apnea. The active titration can be accomplished in an automated fashion by a closed-loop process. The closed-loop process can be executed by a computing device that includes a non-transitory memory storing instructions and a processor to execute the instructions to perform operations. The operations can include defining initial parameters for the one or more cranial or peripheral nerve stimulators for a patient; receiving sensor data from sensors associated with the patient based on a stimulation with the one or more cranial or peripheral stimulators programmed according to the initial parameters; and adjusting the initial parameters based on the sensor data.Type: GrantFiled: August 1, 2019Date of Patent: January 31, 2023Assignee: VANDERBILT UNIVERSITYInventor: David T. Kent
-
Patent number: 11554261Abstract: The present disclosure relates to a system for generating a predefined electrical signal in an MR scanner for use in electrical stimulation of a subject during MRI or functional MRI of said subject, wherein said MR scanner is located inside a shielded MRI room. The system comprises a control unit to be located outside the MRI room for generating an electrical signal and an electrical to optical converter to be located outside the MRI room for converting said electrical signal to a corresponding optical signal. An optical transmitting element, such as an optical fiber, is used for transmitting the optical signal into the MRI room, and an optical to electrical converter is used for converting the optical signal to said predefined electrical signal for electrical stimulation of the subject during magnetic resonance imaging. The optical to electrical converter is configured for being located inside the MRI room and for operation during magnetic resonance imaging.Type: GrantFiled: October 5, 2018Date of Patent: January 17, 2023Assignees: Roskilde/Køge Hospital, Rigshospitalet, University Of CopenhagenInventors: Anders Ohlhues Baandrup, Louise Møller Jørgensen, Carsten Thomsen
-
Patent number: 11547307Abstract: A method for detecting or monitoring respiratory or cardiac health of a patient includes measuring any intravascular or intracardiac pressure (IVP) of a patient over a period of time, said IVP including a measured respiratory wave, defining respiratory effort of the patient as a peak-to-peak amplitude of said respiratory wave, and using the respiratory effort to detect or monitor respiratory and cardiac health of the patient by comparing the respiratory effort with a known value of respiratory effort or by monitoring changes in the respiratory effort of the patient over another period of time.Type: GrantFiled: May 29, 2020Date of Patent: January 10, 2023Assignee: TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD.Inventors: Amir Landesberg, Anna Faingersh-Klebanov
-
Patent number: 11529514Abstract: Devices, systems and methods of neurostimulation for treating obstructive sleep apnea. The system is adapted to send an electrical signal from an implanted neurostimulator through a stimulation lead to a patient's nerve at an appropriate phase of the respiratory cycle based on input from a respiration sensing lead. External components are adapted for wireless communication with the neurostimulator. The neurostimulator is adapted to deliver therapeutic stimulation based on inputs.Type: GrantFiled: March 12, 2018Date of Patent: December 20, 2022Assignee: LivaNova USA, Inc.Inventors: Stephen L. Bolea, Thomas B. Hoegh, Brian D. Kuhnley, Dale G. Suilmann, Bruce J. Persson, John P. Beck, Sidney F. Hauschild, Wondimeneh Tesfayesus, Jason J. Skubitz, Mark R. Bosshard, Daniel A. Parrish, Robert E. Atkinson
-
Patent number: 11497915Abstract: Devices and methods are provided to treat acute and chronic heart failure by using one or more implantable or non-implantable sensors along with phrenic nerve stimulation to reduce intrathoracic pressure and thereby reduce pulmonary artery, atrial, and ventricular pressures leading to reduced complications and hospitalization.Type: GrantFiled: November 9, 2020Date of Patent: November 15, 2022Assignee: RMX, LLCInventor: Amir J. Tehrani
-
Patent number: 11491324Abstract: Intraoral electrical stimulation devices are disclosed. A representative device, which can be used to treat sleep apnea, includes an intraoral attachment body, a guide element carried by the attachment body and having a constrained guide path, and an electrode movably supported relative to the guide element and movable along the constrained guide path to a plurality of positions. A positioning member is coupleable to the electrode to move the electrode along the constrained guide path, and a signal generator is coupleable to the electrode to direct a stimulation signal to the electrode.Type: GrantFiled: October 14, 2020Date of Patent: November 8, 2022Assignee: Invicta Medical, Inc.Inventors: David Herron, Ling-Kang Tong, Hoa D. Nguyen, Chang Yeul Lee
-
Patent number: 11491333Abstract: One aspect of the present disclosure relates to a system for treating obstructive sleep apnea in a subject. The system can include a power source and a neuromuscular stimulator in electrical communications with the power source. The neuromuscular stimulator can include a controller and at least one electrode. The controller can be configured to receive certain power and stimulation parameters associated with a therapy signal from the power source. The at least one electrode can be configured to deliver the therapy signal to a target tissue associated with control of a posterior base of the tongue of the subject.Type: GrantFiled: January 13, 2021Date of Patent: November 8, 2022Assignee: The Cleveland Clinic FoundationInventor: Francis A. Papay
-
Patent number: 11478635Abstract: The invention has a contact assembly including a spatial longitudinal extension which is orientated parallel to the winding axis. The contact assembly is fixedly joined to the carrier substrate along a joining region which has a joining region length orientated in parallel to the winding axis. The orthogonal projection relative to the winding axis overlaps with a first region of the carrier substrate which is wound into a tube.Type: GrantFiled: February 26, 2019Date of Patent: October 25, 2022Assignee: NEUROLOOP GMBHInventors: Tim Boretius, Dennis Plachta, Fabian Kimmig
-
Patent number: 11478630Abstract: Devices, systems and methods are described for providing muscle contraction stimulation therapy to treat myriad diseases, including heart failure, Type 2 diabetes, and peripheral vascular disease using a skin patch or implantable stimulator that includes a multiplicity of electrodes, a processor, a stimulation circuit, one or more sensors and programming for a patient interface unit, wherein the processor is programmed to control selection of a subset of the multiplicity of electrodes and of operation of the stimulation circuit responsive to an indication of an adverse physiologic response. The indication of patient discomfort may be determined by monitoring a physiologic parameter of the subject using the one or more sensors, by direct input from the subject via the patient interface unit programming, or a combination thereof.Type: GrantFiled: December 17, 2018Date of Patent: October 25, 2022Inventors: Dan Sachs, Orhan Soykan
-
Patent number: 11471683Abstract: Methods and systems for treating sleep apnea using electrical stimulation to a patient's upper and/or lower respiratory nerve or muscle are described. A stimulation regimen can be used to achieve upper airway patency and/or rhythmic air flow in a coordinated fashion during sleep. In some cases, diaphragm activity is monitored to determine whether sufficient upper airway patency and/or rhythmic air flow is achieved and maintained. The stimulation regimen may be adjusted based on the diaphragm activity. In some cases, the system includes modularized components so that the components can be customized to an individual's needs.Type: GrantFiled: January 29, 2020Date of Patent: October 18, 2022Assignee: Synapse Biomedical, Inc.Inventor: Anthony R. Ignagni
-
Patent number: 11471685Abstract: A method of treating a patient, comprising: sensing a biological parameter indicative of respiration; analyzing the biological parameter to identify a respiratory cycle; identifying an inspiratory phase of the respiratory cycle; and delivering stimulation to a hypoglossal nerve of the patient, wherein stimulation is delivered if a duration of the inspiratory phase of the respiratory cycle is greater than a predetermined portion of a duration of the entire respiratory cycle.Type: GrantFiled: October 15, 2015Date of Patent: October 18, 2022Assignee: LivaNova USA, Inc.Inventor: Stephen L. Bolea
-
Patent number: 11464971Abstract: A system for selectively blocking nerve fiber activity in a target nerve is provided. The system includes one or more electrodes. The system further includes an electronic control system electrically attached to each electrode to deliver electrical stimulation to a target nerve to block nerve signal transmission of C-fibers in the target nerve such that the nerve signal transmission of A-fibers in the target nerve providing motor function and/or low-threshold sensory function is not blocked. A method of delivering electrical stimulation to selectively block nerve fiber activity in a target nerve and a kit for performing a procedure to selectively block nerve fiber activity are disclosed.Type: GrantFiled: August 24, 2015Date of Patent: October 11, 2022Assignee: Avent, Inc.Inventors: Eric A. Schepis, Phillip A. Schorr, Jeremy D. Ollerenshaw, Roger D. Massengale, Joshua D. White
-
Patent number: 11464976Abstract: Modulation of neural activity of a ganglion, by applying a signal to a sympathetic nerve adjacent to the ganglion, results in preferential reduction of sympathetic signals to an effector, thereby providing ways of treating and preventing conditions associated with exacerbated sympatho-excitation.Type: GrantFiled: December 11, 2018Date of Patent: October 11, 2022Assignee: Galvani Bioelectronics LimitedInventors: Gerald Edwin Hunsberger, Arun Sridhar
-
Patent number: 11400286Abstract: A controller delivers electrical stimulation therapy to a diaphragm through the one or more electrodes, and obtains a signal indicative of a pressure within an intrathoracic cavity from a pressure measurement source. The electrical stimulation therapy is defined by stimulation parameters. The controller obtains at least one additional signal indicative of a pressure within an intrathoracic cavity by changing at least one of the stimulation parameters, and delivering an electrical stimulation therapy to the diaphragm in accordance with the changed one of the plurality of stimulation parameters. The controller repeats the process of obtaining additional signals indicative of pressure based on a changing stimulation parameter by scanning through a range of values for the changing stimulation parameter.Type: GrantFiled: October 17, 2019Date of Patent: August 2, 2022Assignee: VisCardia, Inc.Inventors: Peter T. Bauer, Edward Chinchoy, Jay Snell, Patricia A. Arand
-
Patent number: 11363984Abstract: An automated method and system for diagnosing sleep disorders and predicting treatment effectiveness using data collected on the user using an automated application including questionnaire, facial recognition technology, and historical user and patient data. The data can be used by a diagnostic and treatment prediction algorithm to diagnose sleep disorders, for example sleep apnea, and predict treatment effectiveness. The system is an automated, self-learning algorithm capable of assessing the risk for sleep disorders and predicting treatment effectiveness.Type: GrantFiled: September 12, 2018Date of Patent: June 21, 2022Assignee: SNOOZE, INC.Inventor: Jordan C. Stern
-
Patent number: 11357979Abstract: A system for stimulating body tissue may include a stimulation lead, sensors, and a control unit. The stimulation lead may include one or more energy sources. The control unit may include a processor and non-transitory computer readable medium, and an interface (e.g., touch screen interface) for receiving user inputs and communicating information to the user. The sensors may be configured to provide impedance measurements to the control unit. The control unit may calculate lung gas distributions and/or generate an image modeling lung gas distributions. Stimulation delivered by the stimulation may be adjusted based on the impedance measurements.Type: GrantFiled: May 15, 2020Date of Patent: June 14, 2022Assignee: Lungpacer Medical Inc.Inventors: Douglas G. Evans, Viral S. Thakkar
-
Patent number: 11324658Abstract: A device is provided for controlling the nitric oxide levels within the lungs of a subject. The device comprises a detector for detecting the respiration cycle of the subject and a stimulator for applying an acoustic or vibratory stimulus to the subject. The stimulator is controlled in dependence on the detected respiration cycle. In particular, acoustic stimulation may be provided at the onset of inspiration. In this way, the nitric oxide flow can be controlled in a way to ensure that the paranasal nitric oxide is nearly fully inspired. This provides a higher nitric oxide concentration in the lung/alveoli.Type: GrantFiled: November 23, 2016Date of Patent: May 10, 2022Assignee: Koninklijke Philips N.V.Inventors: Joachim Kahlert, Maria Estrella Mena Benito
-
Patent number: 11324954Abstract: A system for stimulating phrenic nerves to provide smooth breathing patterns is provided. More specifically, by identifying contraction threshold voltages for muscles associated with each of the left and right portions of a patient's diaphragm, a phrenic nerve pacing signal customized for each phrenic nerve may be provided to a patient. More specifically, a voltage of a pacing voltage provided to a first phrenic nerve may be less than the contraction threshold while a voltage of a pacing voltage provided to a second phrenic nerve may be greater than the contraction threshold.Type: GrantFiled: June 1, 2020Date of Patent: May 10, 2022Assignee: Covidien LPInventors: Abhijit Bhattacharya, Berthold Stegemann
-
Patent number: 11266837Abstract: An implantable neurostimulator (INS) and method of use, the INS including an electrical lead having formed thereon at least a pair of bi-polar electrodes, wherein the electrical lead is configured for placement of the pair of bi-polar electrodes proximate protrusor muscles of a patient, a pulse generator electrically connected to the electrical lead and configured to deliver electrical energy to the pair of bi-polar electrodes, the pulse generator having mounted therein a sensor and a control circuit, and the sensor is configured to generate signals representative of an orientation of the pulse generator and communicate the signals to the control circuit and the control circuit is configured to determine the orientation of the pulse generator and deliver electrical energy to the bi-polar electrodes when the determined orientation correlates to a pre-determined orientation.Type: GrantFiled: January 24, 2020Date of Patent: March 8, 2022Assignee: MEDTRONIC XOMED, INC.Inventors: Avram Scheiner, James Hissong
-
Patent number: 11266838Abstract: A device and method for treating a variety of conditions, disorders or diseases with diaphragm/phrenic nerve stimulation is provided.Type: GrantFiled: June 19, 2020Date of Patent: March 8, 2022Assignee: RMX, LLCInventor: Amir J. Tehrani
-
Patent number: 11259801Abstract: A surgical instrument including a housing, an endoscopic portion, a shaft portion and an end effector is disclosed. The endoscopic portion extends distally from the housing and defines a longitudinal axis. The shaft portion is selectively connectable to a distal end of the endoscopic portion. The end effector is selectively connectable to a distal end of the shaft portion.Type: GrantFiled: May 12, 2021Date of Patent: March 1, 2022Assignee: Covidien LPInventors: Michael Zemlok, David Racenet
-
Patent number: 11246622Abstract: An apparatus includes a body, a shaft assembly, an end effector, and a control module. The shaft assembly extends distally from the body and includes an acoustic waveguide. The waveguide is configured to acoustically couple with an ultrasonic transducer. The end effector includes an ultrasonic blade, a clamp arm, an electrode, and a sensor. The ultrasonic blade is in acoustic communication with the waveguide. The clamp arm is operable to compress tissue against the ultrasonic blade. The electrode is operable to apply radiofrequency (RF) electrosurgical energy to tissue. The sensor is operable to sense a condition of tissue contacted by the end effector. The control module is operable to control delivery of ultrasonic power and RF electrosurgical energy through the end effector based on data from the sensor.Type: GrantFiled: August 23, 2019Date of Patent: February 15, 2022Assignee: Cilag GmbH InternationalInventor: Kevin L. Houser
-
Patent number: 11191970Abstract: A device for conveying power from a location external to a subject to a location within the subject may include a flexible carrier and an adhesive on a first side of the carrier. A coil of electrically conductive material may be associated with the flexible carrier. A mechanical connector may be associated with the carrier opposite the adhesive, wherein the mechanical connector is configured to retain a housing and permit the housing to rotate relative to the flexible carrier. At least one electrical portion may be associated with the carrier in a manner permitting electrical connection to be maintained between the flexible carrier and the housing as the housing is rotated.Type: GrantFiled: May 24, 2018Date of Patent: December 7, 2021Assignee: Nyxoah SAInventors: Adi Mashiach, Tim Ruytjens
-
Patent number: 11123557Abstract: An electric stimulator that effectively improves the brain function of patients suffering from brain disorders by applying electric stimulation to the brain of the patient effectively. The electric stimulator can include main electrodes H to be stuck to particular sites of the patient's body extending from the neck part to the head tip part. The particular site may be the temple part, the forehead part above the eyes, the cheek part and the rear neck part. The electric signal to be applied to the main electrodes H is set so as for weak electric current of 100 ?A or less to flow through the patient's body and stimulate the brain. In addition to the application of electric stimulation by the main electrodes H, auxiliary electrodes S may be stuck to the back of the patient.Type: GrantFiled: February 1, 2018Date of Patent: September 21, 2021Assignees: NIHON MEDIX Co., Ltd.Inventors: Kensuke Yamakawa, Norikazu Yoshioka, Hitoshi Aoki
-
Patent number: 11116397Abstract: Aspects of the subject disclosure may include, for example, a system adapted for determining from sensor data collected for a patient over a period of time a normative condition of a biological function of the patient, generating provisioning information according to the normative condition, detecting a first sensor coupled to the patient, and providing the provisioning information to the first sensor to enable the first sensor to detect an abnormal state of the biological function of the patient. Other embodiments are disclosed.Type: GrantFiled: July 14, 2015Date of Patent: September 14, 2021Assignee: Welch Allyn, Inc.Inventors: David E. Quinn, Craig M. Meyerson, John A. Lane, Kenzi L. Mudge
-
Patent number: 11090489Abstract: A method for positioning an intravascular catheter may include inserting the intravascular catheter into a venous system of a patient, wherein the catheter includes a plurality of electrodes, and multiple electrodes of the plurality of electrodes are configured to emit electrical signals; positioning a distal portion of the catheter in a first position; using one or more electrodes of the plurality of electrodes to acquire an ECG signal; based on the acquired ECG signal, adjusting the distal portion of the catheter to a second position different from the first position; identifying at least one first electrode of the plurality of electrodes to stimulate a first nerve; identifying at least one second electrode of the plurality of electrodes to stimulate a second nerve; and stimulating at least one of the first and second nerves to cause a contraction of a respiratory muscle.Type: GrantFiled: December 17, 2018Date of Patent: August 17, 2021Assignee: Lungpacer Medical, Inc.Inventors: Viral S. Thakkar, Douglas G. Evans, Matthew J. Gani